Related Experiment Video
Updated: Feb 8, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
Iryna Prots1, Janina Grosch2, Razvan-Marius Brazdis3
1Department of Stem Cell Biology, Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany; iryna.prots@uk-erlangen.de.
Alpha-synuclein (α-Syn) oligomers disrupt axonal transport and cause energy deficits in human neurons. This study identifies these toxic α-Syn oligomers as key drivers of early axonal dysfunction in synucleinopathies.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Alpha-synuclein (α-Syn) aggregation into oligomers and fibrils is a hallmark of synucleinopathies.
- α-Syn oligomers are known to be toxic in various models, but their specific role in human neuronal neurite pathology is unclear.
Purpose of the Study:
- To investigate the impact of α-Syn oligomers on neurite pathology and axonal transport in human neurons.
- To elucidate the mechanisms underlying α-Syn oligomer-induced neuronal dysfunction.
Main Methods:
- Utilized human induced pluripotent stem cell (iPSC)-derived neurons from a Parkinson's disease patient with an α-Syn gene duplication.
- Employed an α-Syn oligomerization model expressing α-Syn oligomer-forming mutants (E46K, E57K) and wild-type α-Syn.
- Assessed mitochondrial transport, axonal integrity, protein localization, ATP levels, axonal density, and synaptic structure.
Main Results:
- Increased α-Syn oligomers correlated with reduced axonal mitochondrial transport and impaired axonal integrity in human neurons.
- α-Syn oligomerization led to the relocation of transport-regulating proteins (Miro1, KLC1, Tau) and decreased ATP levels.
- Inhibition of α-Syn oligomer formation restored axonal transport deficits.
- High levels of α-Syn oligomers resulted in reduced axonal density and synaptic degeneration.
Conclusions:
- Increased α-Syn dosage and subsequent oligomerization disrupt axonal transport and energy metabolism in human neurons.
- α-Syn oligomers are identified as the critical species responsible for early axonal dysfunction in synucleinopathies.
- These findings highlight α-Syn oligomers as a key therapeutic target for synucleinopathies.
More Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Related Concept Videos
Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence,...
Base-Promoted α-Halogenation of Aldehydes and Ketones
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Neurons: The Axon
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment....
Induced Pluripotent Stem Cells
α-Alkylation of Ketones via Enolate Ions